Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / AKCA - Akcea's Waylivra secures NICE recommendation for ultra-rare inherited disorder


AKCA - Akcea's Waylivra secures NICE recommendation for ultra-rare inherited disorder

  • Akcea Therapeutics (NASDAQ:AKCA), majority-owned affiliate of Ionis Pharmaceuticals (NASDAQ:IONS) announces that the National Institute for Health and Care Excellence (NICE) has issued a positive Final Evaluation Document for WAYLIVRA (volanesorsen) for the treatment of Familial Chylomicronaemia Syndrome (FCS) for routine care on the National Health Service in England.
  • More news on: Akcea Therapeutics, Inc., Ionis Pharmaceuticals, Inc., Healthcare stocks news,
  • Read more ...
Stock Information

Company Name: Akcea Therapeutics Inc.
Stock Symbol: AKCA
Market: NASDAQ
Website: akceatx.com

Menu

AKCA AKCA Quote AKCA Short AKCA News AKCA Articles AKCA Message Board
Get AKCA Alerts

News, Short Squeeze, Breakout and More Instantly...